Is prazosin used for nighttime nightmares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prazosin for Nightmares

Prazosin can be used for nightmares, particularly those associated with PTSD, though recent evidence has led to a downgraded recommendation due to mixed efficacy results, especially in patients on concurrent antidepressants. 1

Current Guideline Position

The American Academy of Sleep Medicine (2018) acknowledges that prazosin remains the first-choice pharmacologic therapy for nightmare disorder despite contradictory evidence, recognizing that many patients respond very well clinically. 1 However, the recommendation was downgraded after a large 304-patient VA study showed no significant benefit over placebo at 26 weeks, with 78% of participants on concurrent antidepressants. 1

Evidence for Efficacy

Supporting Evidence

Multiple smaller RCTs demonstrated significant benefit:

  • Vietnam veterans: Nightmare scores decreased from 6.9 to 3.6 with prazosin versus 7.1 to 6.7 with placebo (mean dose 9.5 mg/day). 1

  • Civilian PTSD patients: An 8-week trial in 100 trauma victims showed nightmare frequency decreased from 2.42 to 0.85 with prazosin versus 2.48 to 2.30 with placebo. 1

  • Active-duty soldiers: A 15-week trial showed 64% marked/moderate improvement with prazosin versus 27% with placebo (p<0.001), using doses of 15.6 mg for men and 7.0 mg for women. 1

  • Meta-analysis (2021): Pooled data from 429 patients showed prazosin significantly improved overall PTSD scores (SMD = -0.31), nightmares (SMD = -0.75), and sleep quality (SMD = -0.57). 2

Contradictory Evidence

The largest trial (304 patients, 26 weeks) found no significant difference between prazosin and placebo on any outcome measure, with mean doses of 14.8 mg/day. 1 This negative result appears driven by an unusually large placebo effect and high rates of concurrent antidepressant use (78%). 2

Critical Medication Interaction

Concurrent SSRI use significantly reduces prazosin efficacy. 1 In the 2013 active-duty soldier trial, total PTSD symptoms decreased by 30.1 points in patients not on SSRIs versus only 9.6 points in those taking SSRIs. 1 This interaction may explain the negative results in the large VA study where most patients were on antidepressants. 1

Dosing Strategy

Start low and titrate slowly to minimize orthostatic hypotension and dizziness:

  • Initial dose: 1 mg at bedtime 1
  • Effective dose range: 1-20 mg, with typical doses of 8-15 mg 1
  • Gender-specific dosing: Men typically require 15.6 mg; women 7.0 mg 1
  • Titrate based on nightmare response over several weeks 1

Safety Profile

Prazosin is generally well-tolerated:

  • Most common side effect: Transient dizziness and mild orthostatic hypotension, which typically resolve during treatment 1
  • No falls or syncopal episodes reported in major trials 1
  • No significant blood pressure changes in most studies 1
  • Rare but serious: Priapism with rapid titration (avoid rapid dose escalation) 3

Clinical Algorithm

For PTSD-related nightmares:

  1. First-line: Consider prazosin if patient is NOT on SSRIs or willing to optimize/discontinue antidepressants 1
  2. Adjunctive therapy: Prazosin works best alongside psychotherapy; 91% of best responders were receiving concurrent psychotherapy 4
  3. Monitoring: Assess nightmare frequency weekly and blood pressure at each dose increase 1
  4. Duration: Benefits may take 8-15 weeks to fully manifest 1
  5. Discontinuation: Nightmares typically return to baseline when prazosin is stopped 1

Important Caveats

  • Not FDA-approved for nightmares: Prazosin is only FDA-approved for hypertension 5
  • Benzodiazepine interaction: Emerging evidence suggests concurrent benzodiazepine use may enhance prazosin efficacy for insomnia and PTSD severity, though this requires confirmation 6
  • Limited non-PTSD data: Evidence primarily supports use in PTSD-related nightmares; one case report describes benefit in cancer-related nightmares 7
  • Avoid in suicidal patients with nighttime-only dosing: One trial paradoxically showed worsening nighttime symptoms with bedtime-only prazosin in suicidal PTSD patients 8

Bottom Line

Prazosin remains a reasonable first-line pharmacologic option for PTSD-related nightmares, particularly in patients not taking SSRIs and receiving concurrent psychotherapy. 1 Start with 1 mg at bedtime and titrate slowly to 10-15 mg based on response and tolerability, monitoring for orthostatic symptoms. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.